Fassier Philippine, Zelek Laurent, Bachmann Patrick, Touillaud Marina, Druesne-Pecollo Nathalie, Partula Valentin, Hercberg Serge, Galan Pilar, Cohen Patrice, Hoarau Hélène, Latino-Martel Paule, Srour Bernard, Gonzalez Rebeca, Deschasaux Mélanie, Touvier Mathilde
Nutritional Epidemiology Research Team (EREN): Inserm U1153, Inra U1125, Cnam, Paris 5, 7 and 13 Universities, Sorbonne Paris Cité Epidemiology and Statistics Research Center, F-93017, Bobigny, France.
Oncology Department, Avicenne Hospital, F-93017, Bobigny, France.
Oncotarget. 2017 May 8;8(33):54640-54653. doi: 10.18632/oncotarget.17676. eCollection 2017 Aug 15.
While many cancer patients are affected by weight loss, others tend to gain weight, which may impact prognosis and risk of recurrence and of second cancer. The aim of this prospective study was to investigate weight variation between before and after cancer diagnosis and socio-demographic, economic, lifestyle and clinical factors associated with moderate-to-severe weight gain.
1051 incident cases of first primary cancer were diagnosed in the NutriNet-Santé cohort between 2009 and 2015. Weight was prospectively collected every 6 months since subjects' inclusion (i.e. an average of 2y before diagnosis). Mean weights before and after cancer diagnosis were compared with paired Student's t-test. Factors associated with moderate-to-severe weight gain (≥5% of initial weight) were investigated by age and sex-adjusted logistic regression.
Weight loss was observed in men (-3.54±4.39kg in those who lost weight, p=0.0002) and in colorectal cancer patients (-3.94±4.40kg, p=0.001). Weight gain was observed in breast and skin cancers (2.83±3.21kg, p=0.04, and 2.96±2.75kg, p=0.04 respectively). Women (OR=1.75[1.06-2.87],p=0.03), younger patients (2.44[1.51-3.70],p<0.0001), those with lower income (OR=1.30[1.01-1.72],p-trend=0.007), lower education (OR=1.32[1.03-2.70],p-trend=0.03), excess weight before diagnosis (OR=1.64[1.12-2.42],p=0.01), lower physical activity (OR=1.28[1.01-1.64],p=0.04) and those who stopped smoking (OR=4.31[1.99-9.35],p=0.005]) were more likely to gain weight. In breast cancer patients, induced menopause was associated with weight gain (OR=4.12[1.76-9.67]), but no association was detected for tumor characteristics or treatments.
This large prospective cohort provided original results on weight variation between before and after cancer diagnosis, highlighting different weight trajectories. Socio-demographic and economic factors appeared to influence the risk of weight gain, illustrating social inequalities in health.
虽然许多癌症患者受体重减轻影响,但其他患者则倾向于体重增加,这可能会影响预后、复发风险和患第二种癌症的风险。这项前瞻性研究的目的是调查癌症诊断前后的体重变化,以及与中度至重度体重增加相关的社会人口统计学、经济、生活方式和临床因素。
2009年至2015年期间,NutriNet-Santé队列中诊断出1051例原发性癌症新发病例。自受试者纳入研究(即诊断前平均2年)以来,每6个月前瞻性收集一次体重。采用配对t检验比较癌症诊断前后的平均体重。通过年龄和性别调整的逻辑回归研究与中度至重度体重增加(≥初始体重的5%)相关的因素。
男性(体重减轻者为-3.54±4.39kg,p=0.0002)和结直肠癌患者(-3.94±4.40kg,p=0.001)出现体重减轻。乳腺癌和皮肤癌患者出现体重增加(分别为2.83±3.21kg,p=0.04和2.96±2.75kg,p=0.04)。女性(OR=1.75[1.06-2.87],p=0.03)、年轻患者(2.44[1.51-3.70],p<0.0001)、收入较低者(OR=1.30[1.01-1.72],p趋势=0.007)、受教育程度较低者(OR=1.32[1.03-2.70],p趋势=0.03)、诊断前超重者(OR=1.64[1.12-2.42],p=0.01)、体力活动较少者(OR=1.28[1.01-1.64],p=0.04)以及戒烟者(OR=4.31[1.99-9.35],p=0.005)更有可能体重增加。在乳腺癌患者中,诱导绝经与体重增加相关(OR=4.12[1.76-9.67]),但未发现与肿瘤特征或治疗有关联。
这个大型前瞻性队列提供了关于癌症诊断前后体重变化的原始结果,突出了不同的体重轨迹。社会人口统计学和经济因素似乎影响体重增加的风险,说明了健康方面的社会不平等。